Home › Funds › RENAISSANCE GROUP LLC › NBIX
RENAISSANCE GROUP LLC position in NBIX
NEUROCRINE BIOSCIENCES INC · Health Care
RENAISSANCE GROUP LLC reported holding 205,932 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$29.2M, representing 1.27% of its reported portfolio and ranking #31 among its reported holdings. RENAISSANCE GROUP LLC has disclosed NBIX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How RENAISSANCE GROUP LLC's NBIX position evolved
RENAISSANCE GROUP LLC first disclosed a stake in NBIX in Q3 2024 at 204,140 shares (US$23.5M). The position peaked in Q2 2026 at 228,970 shares, worth US$38.6M. Across 9 filings, RENAISSANCE GROUP LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 205,932 shares valued at US$29.2M — a reduction of -23,038 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 204.14K | $23.52M | New |
| Q4 2024 | 217.57K | $29.70M | Add |
| Q1 2025 | 212.10K | $23.46M | Reduce |
| Q2 2025 | 251.73K | $31.64M | Add |
| Q3 2025 | 251.63K | $35.32M | Hold |
| Q4 2025 | 252.29K | $35.78M | Hold |
| Q1 2026 | 246.38K | $32.46M | Reduce |
| Q2 2026 | 228.97K | $38.59M | Reduce |
| Q3 2026 | 205.93K | $29.21M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NBIX and 13F data
NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 30 other funds we track also report a position in NBIX — the largest reported positions include Two Sigma Investments (US$349.9M), Renaissance Technologies (US$326.3M), Vestal Point Capital, LP (US$316.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NBIX
- Two Sigma Investments 2.08M sh · $349.92M · Q2 2026
- Renaissance Technologies 2.30M sh · $326.33M · Q3 2026
- Vestal Point Capital, LP 1.88M sh · $316.85M · Q2 2026
- RTW INVESTMENTS, LP 1.27M sh · $213.69M · Q2 2026
More on RENAISSANCE GROUP LLC
FAQ
How long has RENAISSANCE GROUP LLC held NBIX?
RENAISSANCE GROUP LLC has disclosed NBIX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is RENAISSANCE GROUP LLC's current position in NBIX?
As of Q3 2026, RENAISSANCE GROUP LLC holds 205.93K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $29.21M, representing 1.27% of its reported portfolio and ranking #31.
Has RENAISSANCE GROUP LLC been buying or selling NBIX?
In the latest 13F filing (Q3 2026), RENAISSANCE GROUP LLC reduced its position in NBIX. The position peaked in Q2 2026 at 228.97K shares.
Which other funds hold NBIX?
Other major institutional holders of NBIX include Two Sigma Investments, Renaissance Technologies, Vestal Point Capital, LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.